FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091289145> ?p ?o ?g. }

• W2091289145 endingPage "1484" @default.
• W2091289145 startingPage "1476" @default.
• W2091289145 abstract "Tumor necrosis factor is an adipocytokine possessing a well-established lipolytic effect. In Crohn's disease (CD) patients, infliximab therapy may thus result in visceral fat accumulation, which is associated with an increased risk of metabolic syndrome. A total of 132 CD patients were investigated. In a first prospective study, magnetic resonance imaging (MRI) quantification of subcutaneous and visceral abdominal fat was performed before and 8 weeks after initiation of infliximab induction therapy (5 mg/kg at weeks 0, 2, and 6) in 21 responding patients treated for perianal disease. In a second prospective study, fasting glycemia, glycated hemoglobin (HbA1c), HDL, LDL, and total cholesterol and triglyceride levels were assessed in 111 responding patients receiving infliximab infusions every 8 weeks, with a mean follow-up of 41 weeks. A significant homogeneous 18% increase in total abdominal fat was observed in the 21 CD patients after infliximab induction therapy (P = 0.027), independently of body mass index evolution. Infliximab maintenance therapy was associated with a decrease in glycemia (P < 0.0001) and HbA1c (P = 0.0005) concentrations, together with an increase in both total cholesterol (P = 0.02) and HDL cholesterol (P = 0.008) concentrations. All glycemic and lipid parameters remained within the normal range throughout the study. Infliximab induction therapy is associated with a significant increase in abdominal fat tissue in CD patients. Infliximab maintenance therapy has no deleterious effects on lipid profile and is accompanied by a decrease in glycemia and HbA1c concentrations, probably by reversing the impairment of tumor necrosis factor-induced insulin-mediated glucose uptake." @default.
• W2091289145 created "2016-06-24" @default.
• W2091289145 creator A5003479866 @default.
• W2091289145 creator A5005058713 @default.
• W2091289145 creator A5005205127 @default.
• W2091289145 creator A5015470174 @default.
• W2091289145 creator A5020070547 @default.
• W2091289145 creator A5042884495 @default.
• W2091289145 creator A5053831258 @default.
• W2091289145 creator A5073322732 @default.
• W2091289145 creator A5073565953 @default.
• W2091289145 creator A5087339363 @default.
• W2091289145 date "2009-10-01" @default.
• W2091289145 modified "2023-10-18" @default.
• W2091289145 title "Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohnʼs disease" @default.
• W2091289145 cites W1829599569 @default.
• W2091289145 cites W1884955980 @default.
• W2091289145 cites W1968702861 @default.
• W2091289145 cites W1975537939 @default.
• W2091289145 cites W1976525661 @default.
• W2091289145 cites W1990911663 @default.
• W2091289145 cites W1999540978 @default.
• W2091289145 cites W2010447832 @default.
• W2091289145 cites W2013531988 @default.
• W2091289145 cites W2018410379 @default.
• W2091289145 cites W2022640174 @default.
• W2091289145 cites W2024032544 @default.
• W2091289145 cites W2026116536 @default.
• W2091289145 cites W2048515853 @default.
• W2091289145 cites W2055627344 @default.
• W2091289145 cites W2072781226 @default.
• W2091289145 cites W2073913626 @default.
• W2091289145 cites W2088679633 @default.
• W2091289145 cites W2091419870 @default.
• W2091289145 cites W2095013915 @default.
• W2091289145 cites W2110500106 @default.
• W2091289145 cites W2113155951 @default.
• W2091289145 cites W2118330616 @default.
• W2091289145 cites W2118829446 @default.
• W2091289145 cites W2123067184 @default.
• W2091289145 cites W2129316761 @default.
• W2091289145 cites W2131872763 @default.
• W2091289145 cites W2145807308 @default.
• W2091289145 cites W2146786120 @default.
• W2091289145 cites W2149019212 @default.
• W2091289145 cites W2152024122 @default.
• W2091289145 cites W2153419357 @default.
• W2091289145 cites W2153797344 @default.
• W2091289145 cites W2154483596 @default.
• W2091289145 cites W2165047605 @default.
• W2091289145 cites W2165107045 @default.
• W2091289145 cites W2167453543 @default.
• W2091289145 cites W2167844752 @default.
• W2091289145 cites W2168743569 @default.
• W2091289145 cites W2169232442 @default.
• W2091289145 cites W2170973130 @default.
• W2091289145 cites W2171341132 @default.
• W2091289145 cites W2172257129 @default.
• W2091289145 cites W2312880025 @default.
• W2091289145 cites W2317184793 @default.
• W2091289145 cites W2345964918 @default.
• W2091289145 cites W4235021382 @default.
• W2091289145 doi "https://doi.org/10.1002/ibd.20931" @default.
• W2091289145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19291781" @default.
• W2091289145 hasPublicationYear "2009" @default.
• W2091289145 type Work @default.
• W2091289145 sameAs 2091289145 @default.
• W2091289145 citedByCount "57" @default.
• W2091289145 countsByYear W20912891452012 @default.
• W2091289145 countsByYear W20912891452013 @default.
• W2091289145 countsByYear W20912891452014 @default.
• W2091289145 countsByYear W20912891452015 @default.
• W2091289145 countsByYear W20912891452016 @default.
• W2091289145 countsByYear W20912891452017 @default.
• W2091289145 countsByYear W20912891452018 @default.
• W2091289145 countsByYear W20912891452019 @default.
• W2091289145 countsByYear W20912891452020 @default.
• W2091289145 countsByYear W20912891452021 @default.
• W2091289145 countsByYear W20912891452022 @default.
• W2091289145 countsByYear W20912891452023 @default.
• W2091289145 crossrefType "journal-article" @default.
• W2091289145 hasAuthorship W2091289145A5003479866 @default.
• W2091289145 hasAuthorship W2091289145A5005058713 @default.
• W2091289145 hasAuthorship W2091289145A5005205127 @default.
• W2091289145 hasAuthorship W2091289145A5015470174 @default.
• W2091289145 hasAuthorship W2091289145A5020070547 @default.
• W2091289145 hasAuthorship W2091289145A5042884495 @default.
• W2091289145 hasAuthorship W2091289145A5053831258 @default.
• W2091289145 hasAuthorship W2091289145A5073322732 @default.
• W2091289145 hasAuthorship W2091289145A5073565953 @default.
• W2091289145 hasAuthorship W2091289145A5087339363 @default.
• W2091289145 hasBestOaLocation W20912891451 @default.
• W2091289145 hasConcept C126322002 @default.
• W2091289145 hasConcept C134018914 @default.
• W2091289145 hasConcept C141071460 @default.
• W2091289145 hasConcept C17991360 @default.
• W2091289145 hasConcept C188816634 @default.
• W2091289145 hasConcept C2777138892 @default.

• next